Identifying novel hits against a disease-relevant protease

Beactica initiates drug discovery collaboration with Medivir

First results confirm drug discovery potential of the European Lead Factory

European Lead Factory is a novel, open-innovation platform for drug discovery, managed by an international consortium of 30 partners

Malaria trial results presented

Results from exploratory Phase I/II clinical trial in uncomplicated malaria

Optimise drug screening processes

Crown Bioscience to showcase progression in human surrogate trials at the 50th ASCO Annual Meeting

Second technology deal successfully closed

Sygnis announces Double Switch technology patent deal with Systasy Bioscience

Double Switch technology patent deal

SYGNIS' proprietary Double Switch technology addresses key needs in proteomics and drug development

Brain atrophy slowed in patients treated with Lemtrada

Slowing of brain atrophy and reductions in new MS lesions in patients treated with Lemtrada

3D visualisation of field patterns

New release makes wide range of Cresset’s drug discovery software available through Pipeline Pilot interface

Resistance to current drugs spurs treatment innovation in influenza, respiratory syncytial virus, chlamydia and gonorrhoea

Next-generation therapeutics for infectious diseases conquer the global spotlight, finds Frost & Sullivan

Prostate cancer: 30 per cent reduction in mortality

Results achieved in a global clinical drug trial for the treatment of prostate cancer

Prostate cancer: 30 per cent reduction in mortality

Results achieved in a global clinical drug trial for the treatment of prostate cancer

Ibuprofen no good in treating colds or sore throats

Questions have been raised about the advice given to patients with a cold and sore throat, in research published in the British Medical...

Webinar addresses 3D cell-based models for regenerative medicine

Presented by Dr Elad Katz, a senior scientist at AMSBIO, a new on-demand webinar explores the potential of 3D cell-based models for...

Propofol discovery may help lead to development of new anaesthetics

New research on the most commonly used anaesthetic drug could help to unravel a long-standing mystery about how it induces a pain-free, sleep-like state.

Toolkit for nucleosome & histone research

AMSBIO has announced addition of new biotinylated histones and nucleosomes to its expanding range of recombinant nucleosomes, purified...

Presenting phenotypic screening strategies for chronic pain research

Cellectricon, a leading provider of advanced cell-based screening technologies and services, invites researchers to join the webinar...

University launches search for ‘returning’ scientists

The University of York has launched an initiative to attract more scientists, who have taken a career break, back into the world of...

Polyphor achieves first milestone in macrocycle drug discovery collaboration with Boehringer Ingelheim

Polyphor, a research-driven pharmaceutical company and leader in the discovery and development of macrocyclic drugs, has announced that Boehringer Ingelheim has decided to enter into the next stage of its drug discovery collaboration with...

Men with incurable prostate cancer living for twice as long as decade ago

Patients with advanced prostate cancer treated with the latest therapies are living on average for more than twice as long as a decade ago, a striking new analysis reveals.



Twitter Icon © Setform Limited